Mersana Therapeutics Inc [NASDAQ: MRSN] price plunged by -10.28 percent to reach at -$0.33. The one-year MRSN stock forecast points to a potential upside of 55.69. The average equity rating for MRSN stock is currently 1.44, trading closer to a bullish pattern in the stock
Mersana Therapeutics Inc [NASDAQ: MRSN] stock went on a downward path that fall over -12.80% on Thursday, amounting to a one-week price decrease of less than -14.44%. The company report on February 28, 2024 at 7:00 AM that Mersana Therapeutics Provides Business Update and Announces Fourth
Mersana Therapeutics Inc [NASDAQ: MRSN] price surged by 1.32 percent to reach at $0.05. The company report on February 1, 2024 at 8:00 AM that Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference. About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical company focused
Mersana Therapeutics Inc [NASDAQ: MRSN] surged by $0.64 during the normal trading session on while it closed the day at $4.23. The company report on February 1, 2024 at 8:00 AM that Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference. About Mersana TherapeuticsMersana
© 2024, Powered by Smart TechOne
